261 related articles for article (PubMed ID: 18461312)
1. The immunogenetics of multiple sclerosis.
Svejgaard A
Immunogenetics; 2008 Jun; 60(6):275-86. PubMed ID: 18461312
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
3. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
4. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
5. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
[TBL] [Abstract][Full Text] [Related]
6. Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.
González-Enríquez GV; Torres-Mendoza BM; Márquez-Pedroza J; Macías-Islas MA; Ortiz GG; Cruz-Ramos JA
Immunogenetics; 2018 Aug; 70(8):547-551. PubMed ID: 29397401
[TBL] [Abstract][Full Text] [Related]
7. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2.
Zipp F; Windemuth C; Pankow H; Dichgans J; Wienker T; Martin R; Müller C
Hum Immunol; 2000 Oct; 61(10):1021-30. PubMed ID: 11082515
[TBL] [Abstract][Full Text] [Related]
9. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients.
Amirzargar A; Mytilineos J; Yousefipour A; Farjadian S; Scherer S; Opelz G; Ghaderi A
Eur J Immunogenet; 1998 Aug; 25(4):297-301. PubMed ID: 9777330
[TBL] [Abstract][Full Text] [Related]
10. Analysis of HLA-class II DQA1, DQB1, DRB1 and DPB1 in Italian multiple sclerosis patients.
Ciusani E; Allen M; Sandberg-Wollheim M; Eoli M; Salmaggi A; Milanese C; Nespolo A; Gyllensten U
Eur J Immunogenet; 1995 Apr; 22(2):171-8. PubMed ID: 7605774
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.
Barcellos LF; Oksenberg JR; Begovich AB; Martin ER; Schmidt S; Vittinghoff E; Goodin DS; Pelletier D; Lincoln RR; Bucher P; Swerdlin A; Pericak-Vance MA; Haines JL; Hauser SL;
Am J Hum Genet; 2003 Mar; 72(3):710-6. PubMed ID: 12557126
[TBL] [Abstract][Full Text] [Related]
12. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.
Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Palmgren J; Hillert J
PLoS One; 2007 Jul; 2(7):e664. PubMed ID: 17653284
[TBL] [Abstract][Full Text] [Related]
13. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DR beta 1 chain in multiple sclerosis.
Ghabanbasani MZ; Gu XX; Spaepen M; Vandevyver C; Raus J; Marynen P; Carton H; Cassiman JJ
J Neuroimmunol; 1995 Jun; 59(1-2):77-82. PubMed ID: 7797622
[TBL] [Abstract][Full Text] [Related]
14. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia.
Marrosu MG; Murru R; Murru MR; Costa G; Zavattari P; Whalen M; Cocco E; Mancosu C; Schirru L; Solla E; Fadda E; Melis C; Porru I; Rolesu M; Cucca F
Hum Mol Genet; 2001 Dec; 10(25):2907-16. PubMed ID: 11741834
[TBL] [Abstract][Full Text] [Related]
15. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G
Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.
Haegert DG; Swift FV; Benedikz J
Neurology; 1996 Apr; 46(4):1107-11. PubMed ID: 8780100
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
18. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles.
Allen M; Sandberg-Wollheim M; Sjögren K; Erlich HA; Petterson U; Gyllensten U
Hum Immunol; 1994 Jan; 39(1):41-8. PubMed ID: 8181961
[TBL] [Abstract][Full Text] [Related]
19. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis.
Celius EG; Harbo HF; Egeland T; Vartdal F; Vandvik B; Spurkiand A
J Neurol Sci; 2000 Sep; 178(2):132-5. PubMed ID: 11018705
[TBL] [Abstract][Full Text] [Related]
20. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
